Stryker Expands Medical Device Testing Lab in India for Global Innovation

Photo:Representative Image

Stryker, a global leader in medical technologies, officially expanded its prototype and testing facility in India today, marking significant growth of its RandD footprint. This advanced 55,600-square-foot facility integrates cutting-edge infrastructure, enhanced microbiology capabilities, and a talented team to drive innovation and ensure product quality across its medical technology portfolio.

“Investing in innovation from India is a focus area for Stryker," said Ram Rangarajan, president of Stryker Global Technology Centre, India. "This new lab represents our commitment to developing medical technologies that improve patient outcomes and comply with the highest regulatory standards."

Stryker's new facility is dedicated to the rigorous life cycle testing of medical devices. The new lab boasts several key features like a prototyping and product assurance hub, Equipped with state-of-the-art infrastructure for plastic 3D printing, metal machining, and diverse testing capabilities.

The lab strengthens Stryker's ability to conduct comprehensive microbiological testing, ensuring the safety and efficacy of its medical technologies.

Highly skilled engineers and microbiologists will use the advanced equipment and expertise to develop innovative solutions that positively impact patients worldwide.

“This lab expansion further strengthens our Stryker Global Technology Centre and marks a significant milestone in our commitment towards fostering innovation from India. By leveraging the talent and expertise in the country, Stryker aims to develop medical technologies that benefit patients worldwide,” he said.